type-2

Documents about type-2

• Bioequivalence Study of Sitagliptin Hydrochloride / Metformin Hydrochloride Extended-release Film Coated Tablets 100 mg /1000 mg (FDC) in Healthy Adult Male and Female Subjects Under Fasting Conditions.#154860ClinicalTrials.gov
• The Effect of Addition of Metformin to SGLT2 In Diabetic Patients With Heart Failure With Preserved Ejection Fraction#180329ClinicalTrials.gov
• The Effect of Integrated Lifestyle Intervention Incorporating Calorie-Carbohydrate Restriction With or Without Time-Restricted Feeding for Remission of Type 2 Diabetes (DIREM): A Single Blind Randomised Controlled Trial.#4074NCBI PubMed Central
• Metal‐Catalyzed C(sp 2 )–H Bond Functionalization of Indolinone‐ and Indanone‐Type Chemical Platforms En Route Toward Late‐Stage Functionalization#20714HAL (France)
• The Efficacy and Safety of DWP16001 in Combination With Metformin in T2DM Patients Inadequately Controlled on Metformin#121316ClinicalTrials.gov
• Risk of Hypoglycemia in the Transition From Inpatient to Outpatient Setting. Comparative Study of Basal-bolus Insulin Versus Basal Insulin Plus GLP-1 Analogue#127784ClinicalTrials.gov
• Lot n°2: Fourniture de véhicules d'occasion type camion benne amovible - véhicule utilitaire châssis cabine normale de 3,5 T maxi de PTAC#135213EU Publications
• Lot n°2: Fourniture de véhicules d'occasion type camion benne amovible - véhicule utilitaire châssis cabine normale de 3,5 T maxi de Ptac#135217EU Publications
• Adult persons with type 2 diabetes and family engagement in diabetes self-management education and support: what works, for whom, under what circumstances and how? - a realist review protocol.#156797NCBI PubMed Central
• Comparison of Safety and Efficacy of Needle-Free Injector and Insulin Pen in Patients With T2DM#162384ClinicalTrials.gov
• Algarve Active Ageing - Cardiac and Osteoarthritis Rehabilitation (A3-COR)#174978ClinicalTrials.gov
• Clinical Potential of GIP in Type 2 Diabetes and Obesity.#178991Apollo
• Study of the influence of hardening on sol-gel-type anti-reflective coatings characterized by ultrasound#11458HAL (France)
• A Multicentre, Prospective, Non-Interventional Single-Arm Study Investigating the Impact of Once-Daily Oral Semaglutide in a Real-World Adult Population With Type 2 Diabetes in Mexico.#28290NCBI PubMed Central
• Value of SGLT2 Inhibitor (Dapagliflozin) as an Added Therapy in Diabetic Patients With Heart Failure With Reduced Ejection Fraction; Randomized Controlled Clinical Trial#121518ClinicalTrials.gov
• Lifestyle interventions to prevent gestational and type 2 diabetes among migrant women from low- and middle-income countries: a systematic review#123339Europe PMC
• Canagliflozin attenuates CMR-quantified myocardial fibrosis in individuals with type 2 diabetes mellitus at high cardiovascular risk: a randomised open-label controlled trial#130677Springer Nature OA
• Pre-diabetes in Subject With Impaired Fasting Glucose (IFG) and Impaired Glucose Tolerance (IGT)#143809ClinicalTrials.gov
• Design of a randomized controlled trial to test the efficacy of interrupting sitting on type 2 diabetes risk factors in children with overweight/obesity: The sedentary behavior study 3 protocol.#148294NCBI PubMed Central
• Cardiovascular risk assessment with SCORE2 and targeted health dialogues in primary care patients with mental illness#152686PLOS
• Is AMP‐activated protein kinase activation a central mechanism of cardio‐metabolic outcomes after metabolic and bariatric surgery?#172934HAL (France)
• Beverage Consumption Patterns and Their Association with Metabolic Health in Adults from Families at High Risk for Type 2 Diabetes in Europe—The Feel4Diabetes Study#20021DOAJ
• A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Doses of JNJ-38431055, Sitagliptin, and Co-administration of JNJ-38431055 and Sitagliptin#123641ClinicalTrials.gov
• Essential connections: the impact of a hospital-to-community referral intervention on nutrition care and health outcomes in older adults with malnutrition: a hybrid type 2 implementation effectiveness study protocol.#150310NCBI PubMed Central
• Mental health burden associated with specific ocular conditions among Medicare Advantage beneficiaries with type 2 diabetes: examining the impact of glaucoma, cataracts, retinopathy, and dry eye on unhealthy mental health days.#152283NCBI PubMed Central
• Health Insurance Expenditure Structure for Type 2 Diabetes Treatment in Vietnam by Hospital Classification, 2018-2022: A Descriptive Analysis of Claims Data From Hanoi and Ho Chi Minh City#162306bioRxiv / medRxiv
• Phase 1b/2a Study of GSBR-1290 in Adult Overweight or Obese Healthy Subjects and Subjects With Type 2 Diabetes Mellitus#162397ClinicalTrials.gov
• Development of a complex digital lifestyle intervention for individuals with prediabetes - Using the Medical research Council (MRC) framework.#9624PubMed
• Survey of Patient and Physician Awareness and Values to the Diagnosis and Treatment of Reduced Kidney Function (Chronic Kidney Disease) in Patients With High Blood Sugar Level (Type 2 Diabetes) (AWARE-CKD in T2D)#126017ClinicalTrials.gov
• High vs Low Dose Vitamin D in Patients With Diabetic Peripheral Neuropathy#146368ClinicalTrials.gov
• A Study to Evaluate the Efficacy and Safety of Dual add-on Therapy With Gemigliptin 50 mg and Dapagliflozin 10 mg Added to Metformin Who Have Inadequate Glycemic Control on Metformin Alone#146420ClinicalTrials.gov
• A Clinical Trial to Evaluate the Preference Regarding Convenience of Medication and Efficacy/Safety of SUGAMET®XR Tablet 5/1000mg#148714ClinicalTrials.gov
• Investigation of the Evolution of Gastric Emptying by Gastric Ultra Sonography in Patients Treated With GLP-1 Receptor Agonists on a 7 Days Pausing Period.#158144ClinicalTrials.gov
• Effects of Henagliflozin on the Brain Function in T2DM Patients With Mild Cognitive Impairment: a Randomized, Parallel Controlled Clinical Trial#160325ClinicalTrials.gov
• 3 Formulations of Hib-MenCY-TT Vaccine & 1 Formulation of Hib-MenC-TT Vaccine Compared to Licensed Meningococcal Serogroup C Conjugate Vaccine, Each Administered at 2,3,4 Mths of Age#180223ClinicalTrials.gov
• A Study to Evaluate the Food Effect on Drug Availability, Pharmacokinetic (PK) Properties, Safety and Tolerability of Two Different Dose Combination Therapy of Saxagliptin/Dapagliflozin/Metformin Extended-release (XR) Against Individual Component Co-administration.#136275ClinicalTrials.gov
• A Clinical Trial in Healthy Volunteers and Volunteers With Recurrent Genital Herpes to Study the Safety, Tolerability, and Immune Responses After Vaccination With an Investigational Vaccine Designed to Prevent Genital Herpes Lesions#162566ClinicalTrials.gov
• Sustained glucagon-like peptide-1 receptor agonist treatment improves glycemic control and reduces all-cause mortality compared to dipeptidyl peptidase-4 inhibitors: A real-world target trial emulation in type 2 diabetes.#9125NCBI PubMed Central
• Comparative evaluation of oxidative stress biomarkers F2-isoprostanes and 8-OHdG in Parkinson’s disease and Type 2 Diabetes Mellitus: a systematic review and meta-analysis of human studies#130449Unpaywall
• (Table 2) Abundance of bacteria in wet bottom sediments from the Baltic Sea#149696DataCite
• Sample intervals and carbonate content of sediment core CRP-2/2A (Table 1)#150748DataCite
• Truway Diagnostic Tools in Primary Care#148700ClinicalTrials.gov
• Simulated sample splitting approach to address biases due to instrument selection and participant overlap in two-sample Mendelian Randomization studies#162573PLOS
• Additional file 5 of Traditional statistics and artificial intelligence-based prognostic models for predicting type 2 diabetes mellitus after gestational diabetes: a systematic review#120742DataCite
• Additional file 5 of Traditional statistics and artificial intelligence-based prognostic models for predicting type 2 diabetes mellitus after gestational diabetes: a systematic review#120743DataCite
• Additional file 4 of Traditional statistics and artificial intelligence-based prognostic models for predicting type 2 diabetes mellitus after gestational diabetes: a systematic review#120744DataCite
• Additional file 4 of Traditional statistics and artificial intelligence-based prognostic models for predicting type 2 diabetes mellitus after gestational diabetes: a systematic review#120745DataCite
• Comparative evaluation of oxidative stress biomarkers F2-isoprostanes and 8-OHdG in Parkinson's disease and Type 2 Diabetes Mellitus: a systematic review and meta-analysis of human studies#123333Europe PMC
• Stable isotope data and sedimentology of core PS1235-2#173164DataCite
• BE Study of the Fixed Dose Combination of 5 mg Saxagliptin and 500 mg Metformin HCl XR Tablet Relative to a 5 mg Saxagliptin (Onglyza™) Tablet and a 500 mg Metformin HCl XR (Glifage® XR Marketed in Brazil by Merck S.A.) Tablet Co-Administered to Healthy Subjects in the Fasted and Fed States#126075ClinicalTrials.gov